Dr. Carol Baker, MD

NPI: 1871673293
Total Payments
$42,942
2024 Payments
$5,100
Companies
7
Transactions
34

Payment Breakdown by Category

Consulting$25,873 (60.3%)
Other$12,430 (28.9%)
Travel$3,994 (9.3%)
Food & Beverage$644.79 (1.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $25,873 16 60.3%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,180 4 16.7%
Honoraria $5,250 2 12.2%
Travel and Lodging $3,994 7 9.3%
Food and Beverage $644.79 5 1.5%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $19,905 15 $0 (2024)
Seqirus USA Inc $9,105 3 $0 (2017)
SANOFI PASTEUR INC. $6,867 4 $0 (2021)
Valneva Usa, Inc. $5,425 8 $0 (2024)
Moderna TX, Inc. $1,600 1 $0 (2021)
Merck Sharp & Dohme Corporation $28.75 2 $0 (2019)
Allergan Inc. $11.27 1 $0 (2018)

Payment History by Year

Year Amount Transactions Top Company
2024 $5,100 3 PFIZER INC. ($4,750)
2023 $2,100 3 Valneva Usa, Inc. ($2,100)
2022 $2,975 4 Valneva USA, Inc. ($2,975)
2021 $3,730 3 SANOFI PASTEUR INC. ($1,780)
2020 $11,737 7 PFIZER INC. ($6,650)
2019 $1,126 4 PFIZER INC. ($1,110)
2018 $7,057 6 PFIZER INC. ($7,045)
2017 $9,118 4 Seqirus USA Inc ($9,105)

All Payment Transactions

34 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/15/2024 PFIZER INC. Consulting Fee Cash or cash equivalent $750.00 General
08/08/2024 PFIZER INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,000.00 General
01/10/2024 Valneva Usa, Inc. IXCHIQ (Drug) Consulting Fee Cash or cash equivalent $350.00 General
Category: Vaccine
12/13/2023 Valneva Usa, Inc. Consulting Fee Cash or cash equivalent $700.00 General
07/26/2023 Valneva Usa, Inc. Consulting Fee Cash or cash equivalent $700.00 General
03/21/2023 Valneva Usa, Inc. Consulting Fee Cash or cash equivalent $700.00 General
12/27/2022 Valneva USA, Inc. Consulting Fee Cash or cash equivalent $700.00 General
08/24/2022 Valneva USA, Inc. Consulting Fee Cash or cash equivalent $525.00 General
06/29/2022 Valneva USA, Inc. Consulting Fee Cash or cash equivalent $700.00 General
04/06/2022 Valneva USA, Inc. Consulting Fee Cash or cash equivalent $1,050.00 General
07/21/2021 Moderna TX, Inc. Moderna Covid-19 Vaccine (Biological) Consulting Fee Cash or cash equivalent $1,600.00 General
Category: Infections and Infectious Diseases
05/17/2021 PFIZER INC. Consulting Fee Cash or cash equivalent $350.00 General
04/01/2021 SANOFI PASTEUR INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,780.00 General
10/02/2020 PFIZER INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $700.00 General
09/21/2020 PFIZER INC. Honoraria Cash or cash equivalent $2,800.00 General
07/17/2020 PFIZER INC. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $700.00 General
06/17/2020 PFIZER INC. PREVNAR 13 (Biological) Honoraria Cash or cash equivalent $2,450.00 General
Category: VACCINES
01/22/2020 SANOFI PASTEUR INC. Consulting Fee Cash or cash equivalent $4,788.00 General
01/22/2020 SANOFI PASTEUR INC. Travel and Lodging Cash or cash equivalent $160.00 General
01/22/2020 SANOFI PASTEUR INC. Travel and Lodging Cash or cash equivalent $138.69 General
09/30/2019 PFIZER INC. Consulting Fee Cash or cash equivalent $320.00 General
02/08/2019 Merck Sharp & Dohme Corporation ZERBAXA (Drug), SIVEXTRO Food and Beverage In-kind items and services $15.78 General
Category: INFECTIOUS DISEASE
01/08/2019 PFIZER INC. PREVNAR - 13 (Biological) Travel and Lodging In-kind items and services $150.00 General
Category: VACCINES
01/02/2019 PFIZER INC. Consulting Fee Cash or cash equivalent $640.00 General
12/17/2018 PFIZER INC. PREVNAR - 13 (Biological) Consulting Fee Cash or cash equivalent $5,000.00 General
Category: VACCINES

About Dr. Carol Baker, MD

Dr. Carol Baker, MD is a Pediatric Infectious Diseases healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1871673293.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carol Baker, MD has received a total of $42,942 in payments from pharmaceutical and medical device companies, with $5,100 received in 2024. These payments were reported across 34 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($25,873).

Practice Information

  • Specialty Pediatric Infectious Diseases
  • Location Houston, TX
  • Active Since 10/17/2006
  • Last Updated 07/08/2007
  • Taxonomy Code 2080P0208X
  • Entity Type Individual
  • NPI Number 1871673293

Products in Payments

  • PREVNAR - 13 (Biological) $7,195
  • PREVNAR 13 (Biological) $2,450
  • Moderna Covid-19 Vaccine (Biological) $1,600
  • IXCHIQ (Drug) $350.00
  • ZERBAXA (Drug) $15.78
  • NOXAFIL (Drug) $12.97
  • TEFLARO (Drug) $11.27

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatric Infectious Diseases Doctors in Houston